53P Incidence of febrile neutropenia (FN), adherence and compliance to granulocyte colony-stimulating factor (G-CSF) on-body injector (OBI) versus other FN prophylaxis in patients receiving myelosuppressive chemotherapy: Subgroup analysis in breast cancer patients

Autor: Mahtani, R., Lyman, G.H., Rifkin, R., Dale, D., Brookhart, A., Lewis, S., Decosta, L., Lawrence, T., Belani, R., Crawford, J.
Zdroj: In Annals of Oncology May 2021 32 Supplement 2:S43-S43
Databáze: ScienceDirect